In conclusion, our results suggest that both metformin and calcium-vitamin D3 provide similar hepatoprotective effects in an insulin and AMPK-independent manner, with slightly additional protective benefits of their combination on the steatosis scores and hepatic cholesterol content. Here, INS is linked to steatosis.